Assessment of quality of sleep in psychiatric patients using psqi scale- role of clinical pharmacist

Background: Insomnia is defined as the complaint of difficulty falling asleep, staying asleep or non-restorative sleep. DSM-IV criteria for primary insomnia if the duration is >1month.It causes clinically significant distress or impairment. It does not occur exclusively during the course of a mental disorder. Insomnia is the most commonly observed in co-morbid patients with psychiatric conditions.
Aim: To improve quality of sleep in psychiatric patients with sleep disturbances by providing non-pharmacological support to the patients attending psychiatry.
Objectives:
• To avoid and minimize drug dependence by following non-pharmacological treatment.
• To improve quality of sleep non-pharmacologically
Method: A cross-sectional study was conducted in government general hospital, Guntur. It is approved by the Ethical committee. The quality of sleep is assessed using PSQI scale for a period of 6 months i.e; of December, 2016 to May, 2017.
Results: The were analysed using graphpad prism and graphpad instat. A total number of60 patients, males were 33(58%) and females were 24(42%). From our data, 47% of psychosis patients were observed with sleep disturbances, the level of significance of p-value ˂0.005 shows the improvement in sleep quality was assessed by using PSQI scale after follow-up.
Conclusion: SHE can be used as a supportive therapy for patients who do not need sedatives with psychiatric disorders compared to pre-follow up there was significant improvement in quality of sleep at post-follow up. Clinical pharmacist has a major role in the management of psychiatric disorders by monitoring ADRs, Drug interactions and improving patient related quality of life.